This app isn't in any of our charts yet.
Log GLP-1 shots, rotate injection sites, track side effects, protein and weight
Dose & Lose is a GLP-1 tracker for people on a weekly or daily GLP-1 shot, or a daily GLP-1 pill. Log every dose, rotate injection sites, track side effects and see an estimate of your medication level, with protein, water and weight in the same calm place. Who it's for You take, or are about to start, a prescribed GLP-1 such as semaglutide or tirzepatide, and you want a clear picture of every week: when the next shot is due, how you felt after the last one, and whether you are eating enough protein. A shot tracker that remembers for you • Log dose, time, injection site, pain from 0 to 10 and notes in seconds • Your medication and dose are filled in from your own schedule • A reminder on shot day • Injection site rotation: the app remembers your last site and suggests the next one. You choose. Estimated medication level A chart estimates how much medication is active, from the doses you logged and a fixed model per medication, over 7, 30 or 90 days. It is an estimate, not a lab value. Side effects and symptoms, day by day Rate nausea, fatigue, food noise, constipation and more from 0 to 10, and see them next to your doses. Handy notes for your next appointment. Food and protein tracker Log a meal by search, barcode, quick add or by hand. With Premium, AI reads a meal photo or a nutrition label, and you can log by voice. You always review the result before saving. Daily protein, fiber and water goals help on low-appetite days. Weight and progress Log your weight whenever you like, set a goal and see a chart from a week to a year, with a plain-language summary of what changed since you started your medication. Ask Puku Puku is your AI companion. Ask about food, side effects, your shot routine or your progress, and Puku answers with your own logs in mind. It can also log an item for you. Puku is part of Premium. Puku is not a doctor and can make mistakes. Health Connect and the Puku widget With your permission, Dose & Lose reads steps, workouts, weight and nutrition from Health Connect. It never writes to Health Connect. With Premium, the Puku home screen widget shows today's water, protein, fiber and activity. Private by design No ads. Your data is never sold or used for advertising. Photos are stored privately, and you can delete your account and all your data from inside the app. Works with your GLP-1 Use it as a tracker for Ozempic®, Wegovy® (injection or pill), Rybelsus®, Mounjaro®, Zepbound®, Foundayo™, Trulicity®, Saxenda® or Victoza®, for other semaglutide, tirzepatide, liraglutide and dulaglutide routines, or choose Other. Free to start Logging doses, food (search, barcode, manual), water, weight, side effects and activity is free. Premium adds Puku, your AI companion, AI meal and label scans, voice logging and Fix with AI, plus Journey cards with progress photos and milestones, the Puku home screen widget, a larger food database and Autopilot goals for protein, water and activity. Premium is a subscription billed through Google Play; you can cancel it any time in Google Play. Terms of Use: https://doseandlose.com/terms Privacy Policy: https://doseandlose.com/privacy Dose & Lose is for tracking and education only. It is not a medical device. It does not give medical advice, does not diagnose or treat any condition, and does not recommend doses or dose changes. Always follow your prescriber's instructions and talk to them about your medication, side effects and health. Dose & Lose is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company; all trademarks belong to their owners.
past month, based on 1 day
Downloads
Low confidence7
From install count ÷ months since release
In-app revenue
Low confidence$5
From downloads × revenue per download
Ads
$0
No ads
Total
$5
In-app + ads
Google Play only. Downloads from daily Top free ranks (or the store's install count); in-app revenue from Top grossing ranks, calibrated on AppTweak's US estimates, or else from downloads; ads from public ad benchmarks. Not reported figures.